Rx Bandz, LLC SBIR Phase II Award, August 2021

A SBIR Phase II contract was awarded to Rx Bandz in August, 2021 for $749,947.0 USD from the U.S. Department of Defense and United States Air Force.

Overview Structured Data Issues Contributors Activity

sbir.gov/node/2167617

Is a

SBIR/STTR Awards

SBIR/STTR Award attributes

SBIR/STTR Award Recipient

Rx Bandz

Government Agency

U.S. Department of Defense

Government Branch

United States Air Force

Award Type

SBIR0

Contract Number (US Government)

FA8649-21-P-15570

Award Phase

Phase II0

Award Amount (USD)

749,9470

Date Awarded

August 6, 2021

End Date

November 9, 2022

Abstract

Rx Bandz’ innovative MiniJect™ auto-injector can be adapted to deliver the analgesic hydromorphone to severely injured Airmen giving them and their units a better chance of remaining mobile and less exposed in theater and under fire.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like Rx Bandz, LLC SBIR Phase II Award, August 2021

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API